LINC00488 stimulates the progression of esophageal cancer by targeting microRNA‑485‑5p Retraction in /10.3892/ol.2022.13412

Xu,Hongbo; Ye,Yan

doi:10.3892/ol.2020.12347

LINC00488 stimulates the progression of esophageal cancer by targeting microRNA‑485‑5p

Retraction in: /10.3892/ol.2022.13412

Authors:
- Hongbo Xu
- Yan Ye
View Affiliations

Affiliations: Department of Cardiothoracic Surgery, Lu'an Affiliated Hospital of Anhui Medical University, Lu'an, Anhui 237000, P.R. China
Published online on: December 4, 2020 https://doi.org/10.3892/ol.2020.12347
Article Number: 86
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Esophageal cancer is the eighth most prevalent malignancy in the world and China has a high incidence of esophageal cancer. Previous studies have identified that LINC00488 is an oncogene; however, its role in esophageal cancer remains unclear. The present study detected the expression and biological functions of LINC00488 in the progression of esophageal cancer. LINC00488 levels in 45 esophageal cancer and matched paracancerous tissues were detected. The association between LINC00488 level, clinical indexes and overall survival rate of patients with esophageal cancer was analyzed. Using Cell Counting Kit‑8, Transwell and wound healing assays, the influence of LINC00488 on the biological functions of OE19 and OE33 cells were assessed. The target gene of LINC00488, microRNA‑485‑5p (miRNA‑485‑5p), was predicted using bioinformatics databases. In addition, the role of miRNA‑485‑5p in the progression of esophageal cancer was evaluated using rescue experiments. LINC00488 was upregulated in esophageal cancer tissues and cell lines. A high level of LINC00488 was associated with lymphatic and distant metastasis and poor prognosis in patients with esophageal cancer. Silencing LINC00488 attenuated the viability, migration and wound healing of OE19 and OE33 cells. miRNA‑485‑5p was downregulated in esophageal cancer and low expression levels predicted a poor prognosis in these patients. In addition, miRNA‑485‑5p level was negatively correlated with that of LINC00488. Rescue experiments showed that knockdown of miRNA‑485‑5p reversed the attenuated proliferation and migration of esophageal cancer cells with LINC00488‑knockdown. In conclusion, LINC00488 aggravated the malignant progression of esophageal cancer by targeting miRNA‑485‑5p.

View Figures

View References

1	Benjamin T and Thota PN: Synchronous or metachronous occurrence of lesions of different histologic types in patients with esophageal cancer. Clin Gastroenterol Hepatol. 15:780–781. 2017. View Article : Google Scholar : PubMed/NCBI
2	Lu HB: MicroRNA-556-3p promotes the progression of esophageal cancer via targeting DAB2IP. Eur Rev Med Pharmacol Sci. 22:6816–6823. 2018.PubMed/NCBI
3	Cheng Z, Geng H, Cheng Y, Dong N, Ning F, Yu Z, Jian J and Chen S: Effects of MiR-210 on proliferation, apoptosis and invasion abilities of esophageal cancer cells. J BUON. 23:814–819. 2018.PubMed/NCBI
4	Lin Y, Totsuka Y, Shan B, Wang C, Wei W, Qiao Y, Kikuchi S, Inoue M, Tanaka H and He Y: Esophageal cancer in high-risk areas of China: Research progress and challenges. Ann Epidemiol. 27:215–221. 2017. View Article : Google Scholar : PubMed/NCBI
5	Guo LW, Huang HY, Shi JF, Lv LH, Bai YN, Mao AY, Liao XZ, Liu GX, Ren JS, Sun XJ, et al: Medical expenditure for esophageal cancer in China: A 10-year multicenter retrospective survey (2002–2011). Chin J Cancer. 36:732017. View Article : Google Scholar : PubMed/NCBI
6	Schizas D, Lidoriki I and Liakakos T: Can we rely on body mass index when predicting postoperative outcomes and survival of esophageal cancer patients? J BUON. 23:1572018.PubMed/NCBI
7	Wang Y, Zhu L, Xia W and Wang F: Anatomy of lymphatic drainage of the esophagus and lymph node metastasis of thoracic esophageal cancer. Cancer Manag Res. 10:6295–6303. 2018. View Article : Google Scholar : PubMed/NCBI
8	Ma JL, Zhao Y, Guo CY, Hu HT, Zheng L, Zhao EJ and Li HL: Dietary vitamin B intake and the risk of esophageal cancer: A meta-analysis. Cancer Manag Res. 10:5395–5410. 2018. View Article : Google Scholar : PubMed/NCBI
9	Huang X, Zhou X, Hu Q, Sun B, Deng M, Qi X and Lu M: Advances in esophageal cancer: A new perspective on pathogenesis associated with long non-coding RNAs. Cancer Lett. 413:94–101. 2018. View Article : Google Scholar : PubMed/NCBI
10	Fanelli GN, Gasparini P, Coati I, Cui R, Pakula H, Chowdhury B, Valeri N, Loupakis F, Kupcinskas J, Cappellesso R and Fassan M: LONG-NONCODING RNAs in gastroesophageal cancers. Noncoding RNA Res. 3:195–212. 2018. View Article : Google Scholar : PubMed/NCBI
11	Feng Q, Zhang H, Yao D, Chen WD and Wang YD: Emerging role of Non-Coding RNAs in esophageal squamous cell carcinoma. Int J Mol Sci. 21:2582019. View Article : Google Scholar
12	Abraham JM and Meltzer SJ: Long Noncoding RNAs in the pathogenesis of barrett's esophagus and esophageal carcinoma. Gastroenterology. 153:27–34. 2017. View Article : Google Scholar : PubMed/NCBI
13	Shen WJ, Zhang F, Zhao X and Xu J: lncRNAs and esophageal squamous cell carcinoma-implications for pathogenesis and drug development. J Cancer. 7:1258–1264. 2016. View Article : Google Scholar : PubMed/NCBI
14	Lin CY and Xu HM: Novel perspectives of long non-coding RNAs in esophageal carcinoma. Carcinogenesis. 36:1255–1262. 2015. View Article : Google Scholar : PubMed/NCBI
15	Liang WC, Fu WM, Wong CW, Wang Y, Wang WM, Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525. 2015. View Article : Google Scholar : PubMed/NCBI
16	Tang Z, Wei G, Zhang L and Xu Z: Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network. Mol Med Rep. 19:4806–4818. 2019.PubMed/NCBI
17	Gao J, Yin X, Yu X, Dai C and Zhou F: Long noncoding RNA LINC00488 functions as a ceRNA to regulate hepatocellular carcinoma cell growth and angiogenesis through miR-330-5. Dig Liver Dis. 51:1050–1059. 2019. View Article : Google Scholar : PubMed/NCBI
18	Liu H, Wang S, Zhou S, Meng Q, Ma X, Song X, Wang L and Jiang W: Drug resistance-related competing interactions of lncRNA and mRNA across 19 cancer types. Mol Ther Nucleic Acids. 16:442–451. 2019. View Article : Google Scholar : PubMed/NCBI
19	Han DL, Wang LL, Zhang GF, Yang WF, Chai J, Lin HM, Fu Z and Yu JM: miRNA-485-5p, inhibits esophageal cancer cells proliferation and invasion by down-regulating O-linked N-acetylglucosamine transferase. Eur Rev Med Pharmacol Sci. 23:2809–2816. 2019.PubMed/NCBI
20	Gao F, Wu H, Wang R, Guo Y, Zhang Z, Wang T, Zhang G, Liu C and Liu J: MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2. Bioengineered. 10:1–12. 2019. View Article : Google Scholar : PubMed/NCBI
21	Nishimura Y, Nagata K, Katano S, Hirota S, Nakamura K, Higuchi F, Soejima T and Sai H; Japanese Society for Esophageal Diseases, : Severe complications in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents: A questionnaire survey of the Japanese Society for Esophageal Diseases. Int J Radiat Oncol Biol Phys. 56:1327–1332. 2003. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI